Lyfebulb, a patient engagement platform, has launched a new app tailored for individuals navigating life after an organ transplant. The app is designed to help transplant recipients manage the daily complexities of post-surgical life, including medication and symptom tracking, to enhance communication with healthcare providers.
For transplant recipients, the journey doesn’t end after surgery—a new transplant comes with new routines, responsibilities, and the need to stay in control. Lyfebulb’s new app seeks to transform that journey by replacing paper notes with a personal, digital tool that delivers a user-friendly, empowering experience.
At the helm of Lyfebulb is Karin Hehenberger, MD, PhD, a veteran of the life sciences sector with more than two decades of leadership experience at companies like Eyetech Pharmaceuticals, Coronado Biosciences and Johnson & Johnson. A physician-scientist and transplant recipient herself, Dr. Hehenberger brings deep personal and professional insight to the company’s mission.
“Life after a transplant can feel like a full-time job—managing medications, tracking symptoms, remembering questions for your doctor… all while trying to live your life, said Dr. Hehenberger. “We want you to thrive with your transplant. That’s why we built TransplantLyfe365 — an app made for transplant recipients, by transplant providers and patients.”
Key features include symptom and health metric tracking, medication lists and reminders, a personal question log for upcoming healthcare visits, and a “Provider Visit Optimization” tool that generates detailed health reports. The app also ensures secure data storage, making crucial health information accessible when it matters most.
The app is free and is now available for download on iOS and Android.
Lyfebulb, a Patient Care America Company, also operates TransplantLyfe.com, a community platform where pre and post-transplant patients can connect 1:1 or in a forum, access educational seminars, articles and podcasts, and join support groups.
